Hims & Hers Health/$HIMS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Hims & Hers Health
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Ticker
$HIMS
Sector
Primary listing
NYSE
Employees
2,442
Headquarters
Website
HIMS Metrics
BasicAdvanced
$8.2bn
-
-$0.06
2.42
-
Price and volume
Market cap
$8.2bn
Beta
2.42
52-week high
$70.43
52-week low
$13.74
Average daily volume
23m
Financial strength
Current ratio
1.689
Quick ratio
1.455
Long term debt to equity
252.475
Total debt to equity
253.725
Interest coverage (TTM)
2.82%
Profitability
EBITDA (TTM)
83.416
Gross margin (TTM)
72.92%
Net profit margin (TTM)
-0.56%
Operating margin (TTM)
0.64%
Effective tax rate (TTM)
65.28%
Revenue per employee (TTM)
$970,000
Management effectiveness
Return on assets (TTM)
0.60%
Return on equity (TTM)
-2.66%
Valuation
Price to revenue (TTM)
3.391
Price to book
18.34
Price to tangible book (TTM)
-51.89
Price to free cash flow (TTM)
133.054
Free cash flow yield (TTM)
0.75%
Free cash flow per share (TTM)
0.267
Growth
Revenue change (TTM)
32.81%
Earnings per share change (TTM)
-108.57%
3-year revenue growth (CAGR)
56.66%
3-year earnings per share growth (CAGR)
-41.33%
What the Analysts think about HIMS
Analyst ratings (Buy, Hold, Sell) for Hims & Hers Health stock.
HIMS Financial Performance
Revenues and expenses
HIMS Earnings Performance
Company profitability
HIMS News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs